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Abstract
Background: There is accumulating evidence for an increased susceptibility to infection in patients with arthritis.
We sought to understand the epidemiology of Toxoplasma gondii infection in arthritis patients in eastern China,
given the paucity of data on the magnitude of T. gondii infection in these patients.
Methods: Seroprevalence of T. gondii infection was assessed by enzyme-linked immunosorbent assay using a crude
antigen of the parasite in 820 arthritic patients, and an equal number of healthy controls, from Qingdao and Weihai
cities, eastern China. Sociodemographic, clinical and lifestyle information on the study participants were also
obtained.
Results: The prevalence of anti-T. gondii IgG was significantly higher in arthritic patients (18.8%) compared with 12%
in healthy controls (P < 0.001). Twelve patients with arthritis had anti-T. gondii IgM antibodies – comparable with 10
control patients (1.5% vs 1.2%). Demographic factors did not significantly influence these seroprevalence frequencies.
The highest T. gondii infection seropositivity rate was detected in patients with rheumatoid arthritis (24.8%), followed
by reactive arthritis (23.8%), osteoarthritis (19%), infectious arthritis (18.4%) and gouty arthritis (14.8%). Seroprevalence
rates of rheumatoid arthritis and reactive arthritis were significantly higher when compared with controls (P < 0.001
and P = 0.002, respectively). A significant association was detected between T. gondii infection and cats being present
in the home in arthritic patients (odds ratio [OR], 1.68; 95% confidence interval [CI]: 1.24 – 2.28; P = 0.001).
Conclusions: These findings are consistent with and extend previous results, providing further evidence to support
a link between contact with cats and an increased risk of T. gondii infection. Our study is also the first to confirm an
association between T. gondii infection and arthritis patients in China. Implications for better prevention and control
of T. gondii infection in arthritis patients are discussed.
Trial registration: This is an epidemiological survey, therefore trial registration was not required.
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Background
Toxoplasmosis is a parasitic disease caused by infection
with the obligate intracellular apicomplexan protozoan
Toxoplasma gondii. This parasite is able to infect all
warm-blooded animals and chronically infects approxi-
mately one-third of the world’s human population [1]. In
immunocompetent individuals, T. gondii infection
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induces no apparent morbidity. In immunocompromised
individuals however, or patients undergoing immuno-
suppressive treatments or during pregnancy, infection
with T. gondii can cause serious clinical consequences
and even death [2–5]. Many of the clinical manifesta-
tions of acute toxoplasmosis are partially mediated by an
overproduction of the patient’s pro-inflammatory cyto-
kines, e.g. tumor necrosis factor alpha (TNF-α),
interleukin-1 (IL-1) and interferon gamma (IFN-γ) [6],
all of which are important in limiting the parasite’s
growth [7–9].
There is growing interest in exploring the link between
infection with this parasite and autoimmune diseases,
given the propensity of T. gondii infection to occur in
immunocompromised patients [10–14]. Opportunistic
infection with T. gondii is an increasing problem in asso-
ciation with inflammatory rheumatoid arthritis (RA)
[15–17]. A heightened risk of T. gondii infection in pa-
tients with rheumatic diseases can be attributed to alter-
ations in innate and adaptive immune responses [18].
Patients with RA were found to be highly susceptible to
T. gondii infection - particularly during periods of im-
munosuppression that followed treatment with TNF-α
inhibitors [19]. Contrasting data, however, suggest that
T. gondii infection may ameriolate the severity of arth-
ritis - delaying its onset in IL-1 receptor antagonist-
deficient mice via T. gondii-derived Th1 immune
response against Th17 cell-mediated arthritis [20].
Any reduction in the body’s defences against infection
places arthritis patients at risk. Recognising the early
symptoms of infection, while knowing the factors that
increase susceptibility to T. gondii infection in patients
with arthritis, will enable medical professionals to better
assess patients’ needs, plan preventative therapy and
initiate supportive measures. Several questions remain
unanswered: Firstly, it is not clear whether there is an
association between T. gondii infection and an increased
risk of all forms of arthritis, or if the risk is limited to
specific forms of arthritis. Secondly, it is unclear whether
demographic or lifestyle variables increase the risk of T.
gondii infection in arthritis patients. Thirdly, the preva-
lence of T. gondii infection in arthritis patients in China
is still unknown. The present study was designed to in-
vestigate any possible association between T. gondii in-
fection and arthritis by assessing the seroprevalence of,
and risk factors associated with, T. gondii infection in
patients with defined clinical forms of arthritis in eastern
China.
Methods
Study sites
The study was conducted in two cities, Qingdao and
Weihai, in Shandong Province, eastern China (Fig. 1).
Qingdao is located at the south-eastern tip of Shandong
Province (35°35′ – 37°09′N, 119°30′ – 121°00′E) and
Weihai is located at the eastern tip of Shandong prov-
ince (36°41′ – 37°35′N, 121°11′ – 122°42′E).
Study design and data collection
A case-control study was conducted in order to identify
the prevalence of, and risk factors associated with, T.
gondii seropositivity in patients with arthritis. The study
was undertaken between December 2014 and November
2015, and included 820 inpatients hospitalized with the
diagnosis or for treatment of arthritis. The clinical cases
included patients with rheumatoid arthritis (n = 238), re-
active arthritis (n = 122), osteoarthritis (n = 142), infec-
tious arthritis (n = 109) and gouty arthritis (n = 209). An
Fig. 1 Maps of the study sites showing the location of Qingdao and Weihai cities in Shandong province, eastern China
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equivalent number of healthy control subjects (n = 820),
of similar age and gender and from the same geographic
region, were included in the study. We included only
those individuals who had no history or current evidence
of infection or comorbidities. Information on demo-
graphics; such as age, gender and area of residence, was
obtained from the computerized inpatient registry of
cases, or by asking the control individuals. A question-
naire was distributed to adult individuals, and to the par-
ents/guardians of children, in order to obtain
information about their lifestyle and feeding habits - in-
cluding any history of contact with cats in the home
(Yes/No), contact with pigs (Yes/No), the consumption
of raw vegetables (Yes/No), consumption of raw/under-
cooked meat (Yes/No) and exposure to soil (Yes/No).
All personal information was anonymized and treated as
strictly confidential.
Serum collection and serological testing
Approximately 5 ml of venous blood was drawn from
each participant. Blood samples were stored overnight at
ambient temperature, in order to allow blood clot for-
mation, and then centrifuged at 1000×g for 10 min. The
sera were collected in 2-ml Eppendorf tubes and kept at
4 °C for 24 – 48 h, until they were transported in an ice-
box to the State Key Laboratory of Veterinary Etiological
Biology, Lanzhou Veterinary Research Institute, Chinese
Academy of Agricultural Sciences, Gansu Province.
Samples were stored (−20 °C) at the State Key Labs until
analysis. Serum samples were analyzed for the presence
of anti-T. gondii IgG and IgM antibodies using commer-
cially available ELISA kits (Demeditec Diagnostics
GmbH, Germany), according to the manufacturer’s in-
structions. Positive and negative serum controls were in-
cluded in each plate. There was a concern that sera from
RA patients might contain Rheumatoid factor (RF) auto-
antibody, which could potentially cross react non-
specifically with IgM, leading to a false-positive result in
the T. gondii IgM ELISA test [21]. Future work should
consider using RF Neutralization Reagents (RFNR) to re-
move the RF from positive IgM specimens, then retest-
ing these specimens. Samples would not be interpreted
as positive for the specific IgM antibodies, unless they
remained positive following adsorption with the RFNR.
Statistical analysis
Statistical analysis was performed using the statistical
software SPSS v19.0. For the univariate analysis, Chi-s-
quare test or Fisher’s exact test provided a comparison
of the categorical variables. The Mantel-Haenszel test
was used to probe any differences between patient and
control groups. Multivariate logistic regression models
were used to adjust for potential confounders. Variables
associated with T. gondii infection in univariate analysis
(P ≤ 0.10) were included in a multivariate logistic regres-
sion analysis. Odds ratios (ORs) and the corresponding
95% confidence interval (CI) were calculated, in order to
identify independent risk factors for T. gondii infection.
Results with a P-value <0.05 were considered as statisti-
cally significant.
Results
Epidemiology of arthritic patients with T. gondii infection
A total of 1640 individuals (820 arthritis patients and
820 health controls) were examined between December
2014 to November 2015. A significant difference
(P < 0.001) was detected in the level of anti-T. gondii
IgG antibodies in 154 arthritis patients (18.8%) vs. 98
control subjects (12%). Twelve patients tested positive
for T. gondii IgM antibodies (prevalence, 1.5%), com-
pared with 10 controls (1.2%) (P = 0.66). The details of
arthritis patients and control subjects, including age dis-
tribution, gender, geographic region and area of resi-
dence are shown in Table 1. There was no evidence of a
statistically significant association between being T.
gondii seropositive and any of the tested variables, ex-
cept for the ≤30-year-old age group (26.5%) and the
>70-year-old age group (28.9%), which recorded the
highest prevalence (Table 1). Our analysis revealed no
significant differences between female (21.2%) and male
(18.8%) arthritis patients (P = 0.414). T. gondii infection
seroprevalence was not significantly different between
urban and rural areas (17.9% vs. 22.2%; P = 0.128).
Seropositivity among patients with arthritis
Seroprevalence is presented in Table 2, by each clinical
form of arthritis. The highest seropositivity rate of T.
gondii infection was detected in patients with rheuma-
toid arthritis (24.8%), followed by reactive arthritis
(23.8%), osteoarthritis (19%), infectious arthritis (18.4%)
and gouty arthritis (14.8%). Patients with rheumatoid
arthritis and reactive arthritis had significantly higher
seroprevalence when compared with control subjects
(P < 0.001 and P < 0.002, respectively).
Domestic risk factors associated with T. gondii infection
Univariate analysis showed some lifestyle variables with
a P value ≤0.25, including: contact with cats in the
home, contact with pigs, the consumption of raw vegeta-
bles or raw/undercooked meat, and exposure to soil. In
our multivariate analysis, only contact with cats in the
home (OR, 1.68; 95% CI, 1.24 to 2.28; P = 0.001) was as-
sociated with significantly increased odds of T. gondii in-
fection in arthritis patients (Table 3). There was no
evidence of a significant association between patients’ T.
gondii status and the other variables (i.e., contact with
pigs, consumption of raw vegetables or raw/under-
cooked meat, or exposure to soil).
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Discussion
Toxoplasma gondii infection is increasingly being re-
ported in arthritis patients [15–17]; however, both the
epidemiology and impact of this have been unclear. We
assessed the risk of T. gondii infection among 820 arth-
ritis patients from Shandong province, eastern China,
during the period from December 2014 to November
2015; and determined the seroprevalence of anti-T.
gondii antibodies in arthritis patients versus an equal
number of healthy controls. Patients with arthritis were
more likely to be infected with T. gondii (18.8% com-
pared to 12% of healthy controls, P < 0.001), based on
IgG seropositivity. Correlation between T. gondii infec-
tion and RA has been reported in other geographical
areas, for example Iraq (54.0%) [22], Tunisia (58.4%)
[23], Europe (63.0%) [17], and Egypt (54.0% [24] and
76.7% [25]). The higher seroprevalence of anti-T. gondii
IgG antibodies among RA patients versus control pa-
tients reflects an association between latent T. gondii in-
fection and RA. Contrastingly, there was no signficant
difference between RA patients and controls with regard
to the level of IgM antibodies, which was found to be
consistent with a previous study reporting no anti-T.
gondii IgM in RA patients [25]. Among the various clin-
ical forms of arthritis, seroprevalence rates of only
rheumatoid arthritis (24.8%; P < 0.001) and reactive
arthritis (23.8%; P = 0.002) were significantly raised
when compared with controls.
An increased risk of T. gondii infection in RA patients
may be anticipated due to the disease-related immuno-
logical changes that compromise adaptive cellular im-
munity - crucial for the control of an intracellular
pathogen such as T. gondii. RA is associated with alter-
ations in the T cell repertoire [26], a reduction in clonal
Table 1 Socio-demographic characteristics of the study population and seroprevalence of Toxoplasma gondii infection
Variables Arthritis patients (n = 820) Control subjects (n = 820) Patients vs
controls
P* value
Sero-prevalence of T. gondii infection Sero-prevalence of T. gondii infection
No. tested No. positive (%) P* value No. tested No. positive (%) P* value
Age group (years)
≤ 30 102 27 (26.5) Reference 114 18 (15.8) Reference 0.054
31 – 40 154 32 (20.8) 0.290 138 20 (14.5) 0.775 0.161
41 – 50 178 44 (24.7) 0.746 166 23 (13.9) 0.653 0.011
51 – 60 189 30 (15.9) 0.030 220 26 (11.8) 0.309 0.234
61 – 70 145 18 (12.4) 0.005 133 15 (11.3) 0.299 0.770
>70 52 15 (28.9) 0.754 49 5 (10.2) 0.348 0.019
Gender
Male 314 59 (18.8) Reference 366 41 (11.2) Reference 0.005
Female 506 107 (21.2) 0.414 454 66 (14.5) 0.159 0.008
Geographic region
Qingdao 393 77 (19.6) Reference 380 53 (14.0) Reference 0.036
Weihai 427 89 (20.8) 0.656 440 54 (12.3) 0.478 0.001
Residence area
Urban 379 68 (17.9) Reference 387 44 (11.4) Reference 0.036
Rural 441 98 (22.2) 0.128 433 63 (14.6) 0.177 0.001
*Estimated using the χ2 test
Table 2 Clinical diagnosis and seroprevalence of Toxoplasma gondii in arthritis patients in eastern China
Clinical diagnosis Patients with anti-T. gondii antibodies
No. tested No. positive % (95% CI) OR (95% CI) P value
Rheumatoid arthritis 238 59 24.8 (19.48 – 30.70) 2.20 (1.53 – 3.14) <0.001
Reactive arthritis 122 29 23.8 (16.05 – 30.84) 2.09 (1.31 – 3.30) 0.002
Osteoarthritis 142 27 19.0 (13.38 – 25.90) 1.56 (0.98 – 2.49) 0.060
Infectious arthritis 109 20 18.4 (10.89 – 26.26) 1.50 (0.89 – 2.53) 0.132
Gouty arthritis 209 31 14.8 (10.05 – 19.71) 1.16 (0.75 – 1.79) 0.500
Total 820 166 20.2 (17.44 – 23.01) 1.69 (1.30 – 2.21) <0.001
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expansion of naïve T cells in response to a previously
unknown antigen [27] and a reduction in newly gener-
ated naïve T cells migrating from the thymus into the
periphery [27]. The lack of clinical information on the
treatment history of study participants has precluded es-
tablishing corroborative evidence for any link between
the use of immunosuppressive treatment and the fre-
quency of T. gondii seropositivity in RA patients. Im-
munosuppressive therapies frequently used in the
treatment of RA (especially TNF-α inhibitors) have been
known to induce reactivation of latent T. gondii infec-
tion in arthritis patients, and may increase their propen-
sity to acquire new opportunistic infections such as T.
gondii or tuberculosis [28]. Clinical cases of cerebral
toxoplasmosis and chorioretinitis have been reported in
RA patients undergoing treatment with TNF-α antago-
nists [29–32]. Given the important role of TNF-α in
controlling the growth of T. gondii, infection with op-
portunistic pathogens such as T. gondii can be a major
safety concern in patients receiving this therapy. Mea-
sures should therefore be taken to prevent such oppor-
tunistic infections.
Physicians who prescribe TNF-α inhibitor drugs must
understand the therapeutic implications on patients’ im-
munity and the potential risks of infection, in order to
maximize therapeutic benefits and minimize adverse ef-
fects. In rheumatology practice, it is common practice to
screen for tuberculosis, HBV, HCV, HIV and varicella
zoster virus antibodies prior to the initiation of anti-
TNF-α therapy in patients. Patients with arthritis should
be monitored for early signs of opportunistic infection
and, if confirmed, it may be necessary to withdraw anti-
TNF-α therapy until the infection is properly treated.
One study, based on a small sample of only 30 individ-
uals, reported no difference in the level of anti-T. gondii
IgG antibodies among RA patients undergoing treatment
with traditional disease-modifying antirheumatic drugs
or biological TNF inhibitors [25].
Our results showed the highest seroprevalence in indi-
viduals within the ≤30-year-old age and >70-year-old age
groups. Young and elderly individuals may have less
efficient immunity to control opportunistic infections, or
be more likely to interact with cats than those within
other age groups. Previous studies have also shown an
association between age and seropositivity of T. gondii
[5, 33–35]; with higher T. gondii seroprevalence reported
in older RA patients [17]. In our study, no significant
difference in the seropositive rates was observed be-
tween males and females (P = 0.414). However, we
detected a significant association between contact with
cats in the home and T. gondii seropositivity (OR, 1.68;
95% CI, 1.24 to 2.28; P = 0.001), contributing to the
body of evidence suggesting that contact with cats is
associated with an increased risk of T. gondii infection
[5, 35, 36]. Felines are the primary host of T. gondii,
whose oocytes pass with the animal’s stool and cause
toxoplasmosis if ingested by humans or any other inter-
mediate host. Although cats are popular as domestic
pets in China, little attention has been paid to their role
in environmental contamination with T. gondii oocysts
[37, 38]. It is important to inform the general public and
medical professionals about the risk factors of T. gondii
infection - in particular the important role cats can play
in transmitting T. gondii infection to arthritis patients.
Although the association between contact with pigs
and T. gondii seropositivity was not statistically signifi-
cant (P = 0.184), it deserves some attention. The identifi-
cation of contact with cats and with pigs as the two
most important risk factors, is of interest and to be ex-
pected. Human infection can occur via cat-to-pig and
pig-to-human transmission [39]. T. gondii will always be
a risk while cats are maintained in the swine environ-
ment; cats shed millions of oocysts which can survive in
the environment for months or even years, with a single
oocyst having the potential to cause full-blown infection
in a pig. Pork has been implicated as the meat most
commonly associated with food-borne toxoplasmosis
[5]. People who handle pigs, or consume food within pig
facilities, may be less likely to wash their hands before
eating or after handling raw meat, leaving them at higher
risk of infection [40, 41].
Conclusions
This study has demonstrated a high correlation between
anti-T. gondii antibodies and arthritis for the first time
in a population from eastern China, suggesting an in-
creased susceptibility to opportunistic T. gondii infection
in arthritic patients. It remains to be elucidated if
chronic T. gondii infection was a trigger for the develop-
ment of arthritis; whether disease-related immunosup-
pression promoted the reactivation of a latent infection;
or if arthritis patients were idopathically predisposed to
novel infections. TNF-α inhibitors used for the treat-
ment of rheumatic diseases can increase the risk of frank
Table 3 Multivariate analysis of selected variables of arthritis
patients and their association with Toxoplasma gondii infection
Variables Adjusted odds
ratio (OR)
95% Confidence
interval (CI)
P value
Contact with cats
at home
1.68 1.24 – 2.28 0.001
Contact with pigs 1.25 0.90 – 1.72 0.184
Consumption of
raw vegetables
0.96 0.70 – 1.31 0.778
Consumption of
raw/undercooked
meat
1.11 0.93 – 1.33 0.247
Exposure with soil 0.84 0.62 – 1.14 0.266
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toxoplasmosis; therefore, screening for latent T. gondii
infection is strongly recommended before initiating such
therapy. Our study adds to the body of evidence that
contact with cats is associated with an increased risk of
T. gondii infection. These findings should inform Public
Health policy on the risk of opportunistic infections in
arthritis patients.
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